IFOSFAMIDE IN PLASMA-CELL LEUKEMIA - A REPORT OF 2 CASES AND REVIEW OF THE LITERATURE

被引:12
作者
MALHOTRA, H [1 ]
DHABHAR, BN [1 ]
SAIKIA, TK [1 ]
GOPAL, R [1 ]
NADKARNI, KS [1 ]
NAIR, CN [1 ]
ADVANI, SH [1 ]
机构
[1] TATA MEM HOSP,DEPT MED ONCOL,BOMBAY 400012,INDIA
关键词
MYELOMA; IFOSFAMIDE; RESPONSE;
D O I
10.1002/ajh.2830400313
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We report two patients with primary plasma cell leukemia (PCL) treated with a single agent, ifosfamide. One patient had a total disappearance of plasma cells (PC) from the peripheral blood and the bone marrow and disappearance of the myeloma protein, is disease free 8 months after completion of treatment, and alive 14 months after diagnosis. The second patient had a partial response with persistence of plasma cells in the bone marrow lasting 7 months, after which she had a frank relapse of the disease. We suggest that ifosfamide may be an active agent in plasma cell malignancies and needs further evaluation in multiple myeloma.
引用
收藏
页码:226 / 228
页数:3
相关论文
共 21 条